<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-1-32-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-1-5-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Degenerative and Metabolic Diseases</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cerebro-Hepato-Renal (Zellweger) Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>10</month>
<year>1987</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>08</month>
<year>2016</year>
</pub-date>
<volume>1</volume>
<issue>5</issue>
<fpage>32</fpage>
<lpage>32</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1987 The Author(s)</copyright-statement>
<copyright-year>1987</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1007/BF00688256" vol="73" page="333">
<article-title>Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Selective neuronal lipidosis and neuroaxonal dystrophy of the dorsal nucleus of Clarke and lateral cuneate nucleus were the neuropathological findings in 3 males with Zellweger syndrome examined at the Medical Unit S Carolina, Charleston, SC, the John F.</p>
</abstract>
<kwd-group>
<kwd>CNS Neurons</kwd>
<kwd>Fatty Acid Metabolism</kwd>
<kwd>Neuronal Migration Defects</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Selective neuronal lipidosis and neuroaxonal dystrophy of the dorsal nucleus of Clarke and lateral cuneate nucleus were the neuropathological findings in 3 males with Zellweger syndrome examined at the Medical Unit S Carolina, Charleston, SC, the John F. Kennedy Institute, Johns Hopkins Univ, Baltimore, MD, and the Philadelphia Children&#x2019;s Hosp. Large amounts of abnormal cholesterol esters containing saturated and monosaturated very long-chain fatty acids were demonstrated in the striated neurons of the dorsal thoracic cord. The CNS neurons of these patients manifested the same morphological alteration as adrenocortical cells of adreno-leukodystrophy, and many of the striated neurons were degenerate or necrotic. It is suggested that a more generalized defect in neuronal fatty acid metabolism may explain the neuronal migration defects characteristic of Zellweger syndrome. These consist of pachygyria, micropolygyria and cerebral and cerebellar heterotopia. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold><underline>COMMENT</underline></bold>. CHR (Zellweger) syndrome, transmitted as an autosomal recessive, is invariably fatal within a few months after birth. Prenatal diagnosis may be made by amniocentesis and the production of very-long-chain fatty acids (VLCFA) from cultured amniocytes [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>].The determination of VLCFA in the blood permits prompt diagnostic confirmation of CHRS in the infant with dysmorphic facial and skull features, liver enlargement and fibrosis, renal cysts, stippled calcifications of the patellae, Brushfield&#x2019;s spots, optic atrophy and retinal pigmentation. Zellweger syndrome is a peroxisomal disorder. The lacking peroxisomes are cytoplasmic organelles containing oxidases and catalase and are involved in metabolism of hydrogen peroxide, fatty acids and bile acids.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tummons</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Huff</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
</person-group>
<article-title>Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome</article-title>
<source>Acta Neuropathol</source>
<year>1987</year>
<volume>73</volume>
<issue>4</issue>
<fpage>333</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">3618126</pub-id>
<pub-id pub-id-type="doi">10.1007/BF00688256</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bj&#x00F6;rkhem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sisfontes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bostr&#x00F6;m</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kase</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hagenfeldt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Blomstrand</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Possibility of prenatal diagnosis of Zellweger syndrome</article-title>
<source>Lancet</source>
<year>1984</year>
<month>Jun</month>
<day>2</day>
<volume>1</volume>
<issue>8388</issue>
<fpage>1234</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">6144940</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>FR</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Solish</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>PJ</given-names>
</name>
<etal/>
</person-group>
<article-title>The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis</article-title>
<source>N Engl J Med</source>
<year>1984</year>
<month>May</month>
<day>3</day>
<volume>310</volume>
<issue>18</issue>
<fpage>1141</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">6709009</pub-id>
<pub-id pub-id-type="doi">10.1056/NEJM198405033101802</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
